Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Experience with the Direx Tripter X-1].

A Hamvas1, J Kálmán, J Pánovics

  • 1Semmelweis Orvostudományi Egyetem, Budapest.

Orvosi Hetilap
|August 16, 1992
PubMed
Summary

The Direx Tripter X-1 lithotripter achieved an 81.5% stone-free rate for kidney and ureteral stones within 3 months. This extracorporeal shock wave lithotripsy (ESWL) monotherapy proved effective for staghorn calculi, offering potential cost savings.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Der Nervenarzt·2025
Same author

[Relapse prevention of bipolar disorders: a cluster analytical approach in a randomized controlled psychotherapy study].

Der Nervenarzt·2024
Same author

2022 Recommendations of the AFU Lithiasis Committee: Laser - utilization and settings.

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2023
Same author

The excretion of <sup>241</sup>Am and <sup>137</sup>Cs from the broilers organs after long-term application.

Journal of environmental radioactivity·2021
Same author

[Urethro-vesical anastomosis reconstruction using extra-peritoneal robot-assisted laparoscopy for anastomotic stenosis after radical prostatectomy].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2021
Same author

The transfer of 241Am and 137Cs to the tissues of broilers' organs.

PloS one·2020

Area of Science:

  • Urology
  • Medical Devices
  • Nephrology

Context:

  • Renal and ureteral calculi (kidney and ureteral stones) pose a significant health burden.
  • Extracorporeal shock wave lithotripsy (ESWL) is a common treatment modality for urolithiasis.
  • Evaluating the efficacy and practicality of specific lithotripter devices is crucial for clinical decision-making.

Purpose:

  • To assess the effectiveness of the Direx Tripter X-1 for treating renal and ureteral calculi.
  • To evaluate the success rate of ESWL monotherapy using the Direx lithotripter, particularly for staghorn calculi.
  • To determine the operational ease and potential cost-effectiveness of the Direx Tripter X-1.

Summary:

  • The Direx Tripter X-1 achieved an 81.5% stone-free rate in nonselected patients within 3 months.

Related Experiment Videos

  • Successful treatment of staghorn calculi was observed with ESWL monotherapy.
  • The device was found to be effective, easy to operate, and offers significant potential cost reduction.

    • Impact:

    • The Direx lithotripter represents a valuable tool in managing kidney and ureteral stones.
    • This technology may lead to more cost-effective treatments for urolithiasis.
    • Findings support the consideration of the Direx Tripter X-1 in clinical practice for stone disease management.